Napo Pharmaceuticals
Crofelemer
A proprietary gastro-intestinal compound in clinical development for four distinct product indications
 |
 |
 |
|
||
 |
|
 |
|
||
clinical trials
In the pivotal Phase 3 ADVENT Study analyzed in late 2010, crofelemer demonstrated highly statistically significant results in the treatment of chronic diarrhea in people living with HIV/AIDS.